Structure

Physi-Chem Properties

Molecular Weight:  620.41
Volume:  668.684
LogP:  5.992
LogD:  4.723
LogS:  -4.553
# Rotatable Bonds:  7
TPSA:  107.22
# H-Bond Aceptor:  6
# H-Bond Donor:  4
# Rings:  6
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.113
Synthetic Accessibility Score:  5.126
Fsp3:  0.718
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.313
MDCK Permeability:  2.1862999346922152e-05
Pgp-inhibitor:  0.021
Pgp-substrate:  0.005
Human Intestinal Absorption (HIA):  0.007
20% Bioavailability (F20%):  0.258
30% Bioavailability (F30%):  0.952

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.153
Plasma Protein Binding (PPB):  100.00782012939453%
Volume Distribution (VD):  0.738
Pgp-substrate:  2.3261756896972656%

ADMET: Metabolism

CYP1A2-inhibitor:  0.078
CYP1A2-substrate:  0.174
CYP2C19-inhibitor:  0.053
CYP2C19-substrate:  0.596
CYP2C9-inhibitor:  0.162
CYP2C9-substrate:  0.712
CYP2D6-inhibitor:  0.501
CYP2D6-substrate:  0.861
CYP3A4-inhibitor:  0.608
CYP3A4-substrate:  0.325

ADMET: Excretion

Clearance (CL):  4.611
Half-life (T1/2):  0.428

ADMET: Toxicity

hERG Blockers:  0.529
Human Hepatotoxicity (H-HT):  0.261
Drug-inuced Liver Injury (DILI):  0.01
AMES Toxicity:  0.005
Rat Oral Acute Toxicity:  0.027
Maximum Recommended Daily Dose:  0.948
Skin Sensitization:  0.962
Carcinogencity:  0.01
Eye Corrosion:  0.005
Eye Irritation:  0.193
Respiratory Toxicity:  0.824

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC310621

Natural Product ID:  NPC310621
Common Name*:   23,28-Dihydroxylupan-20(29)-Ene-3Beta-Caffeate
IUPAC Name:   [(1R,3aS,5aR,5bR,7aR,8R,9S,11aR,11bR,13aR,13bR)-3a,8-bis(hydroxymethyl)-5a,5b,8,11a-tetramethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
Synonyms:  
Standard InCHIKey:  SSEGSBMQGFCSBY-KEMSSATHSA-N
Standard InCHI:  InChI=1S/C39H56O6/c1-24(2)26-13-18-39(23-41)20-19-37(5)27(34(26)39)9-11-31-35(3)16-15-32(36(4,22-40)30(35)14-17-38(31,37)6)45-33(44)12-8-25-7-10-28(42)29(43)21-25/h7-8,10,12,21,26-27,30-32,34,40-43H,1,9,11,13-20,22-23H2,2-6H3/b12-8+/t26-,27+,30+,31+,32-,34+,35-,36-,37+,38+,39+/m0/s1
SMILES:  C=C(C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@@H]([C@@](C)(CO)[C@@H]5CC[C@@]34C)OC(=O)/C=C/c3ccc(c(c3)O)O)[C@@H]12)CO
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1224891
PubChem CID:   46939047
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO10507 Sorbus decora Species Rosaceae Eukaryota n.a. n.a. n.a. PMID[20738101]
NPO10507 Sorbus decora Species Rosaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO10507 Sorbus decora Species Rosaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2219 Cell Line C2C12 Mus musculus EC50 = 1470.0 nM PMID[559252]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC310621 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9926 High Similarity NPC35212
0.9853 High Similarity NPC252133
0.9852 High Similarity NPC473612
0.9708 High Similarity NPC235557
0.9638 High Similarity NPC26045
0.9632 High Similarity NPC473591
0.9632 High Similarity NPC271494
0.9632 High Similarity NPC155192
0.9559 High Similarity NPC182249
0.95 High Similarity NPC8102
0.95 High Similarity NPC66894
0.9416 High Similarity NPC116742
0.9416 High Similarity NPC139243
0.9407 High Similarity NPC11266
0.9348 High Similarity NPC470617
0.9348 High Similarity NPC470616
0.9236 High Similarity NPC470618
0.9236 High Similarity NPC145527
0.9236 High Similarity NPC208785
0.9236 High Similarity NPC470619
0.9167 High Similarity NPC298647
0.9167 High Similarity NPC273358
0.9155 High Similarity NPC19862
0.9155 High Similarity NPC235195
0.9149 High Similarity NPC477873
0.9149 High Similarity NPC469447
0.9097 High Similarity NPC32017
0.9097 High Similarity NPC96930
0.9048 High Similarity NPC205392
0.9048 High Similarity NPC105942
0.9037 High Similarity NPC30174
0.9034 High Similarity NPC292206
0.9021 High Similarity NPC53520
0.9021 High Similarity NPC280717
0.9021 High Similarity NPC271607
0.9021 High Similarity NPC307205
0.9 High Similarity NPC234548
0.9 High Similarity NPC248287
0.8993 High Similarity NPC476699
0.8897 High Similarity NPC86257
0.8873 High Similarity NPC27518
0.8873 High Similarity NPC304110
0.8851 High Similarity NPC473773
0.8851 High Similarity NPC475579
0.8803 High Similarity NPC471875
0.8794 High Similarity NPC198621
0.8794 High Similarity NPC22676
0.8794 High Similarity NPC475482
0.8794 High Similarity NPC216940
0.8784 High Similarity NPC118033
0.8723 High Similarity NPC249817
0.869 High Similarity NPC25491
0.8662 High Similarity NPC471152
0.8658 High Similarity NPC475311
0.8658 High Similarity NPC473680
0.8658 High Similarity NPC475454
0.8658 High Similarity NPC473579
0.8652 High Similarity NPC173569
0.8652 High Similarity NPC477874
0.8601 High Similarity NPC132723
0.8601 High Similarity NPC76032
0.8535 High Similarity NPC200726
0.8529 High Similarity NPC265413
0.8529 High Similarity NPC10154
0.8523 High Similarity NPC279442
0.8521 High Similarity NPC43353
0.8489 Intermediate Similarity NPC288290
0.8483 Intermediate Similarity NPC472801
0.8481 Intermediate Similarity NPC286809
0.8481 Intermediate Similarity NPC177362
0.8462 Intermediate Similarity NPC154485
0.8462 Intermediate Similarity NPC471872
0.8435 Intermediate Similarity NPC96447
0.8428 Intermediate Similarity NPC266545
0.8428 Intermediate Similarity NPC202428
0.8411 Intermediate Similarity NPC77310
0.8394 Intermediate Similarity NPC474532
0.8389 Intermediate Similarity NPC472937
0.8389 Intermediate Similarity NPC472938
0.8389 Intermediate Similarity NPC472936
0.838 Intermediate Similarity NPC475346
0.838 Intermediate Similarity NPC18982
0.838 Intermediate Similarity NPC475457
0.838 Intermediate Similarity NPC475627
0.8356 Intermediate Similarity NPC172311
0.8288 Intermediate Similarity NPC164743
0.828 Intermediate Similarity NPC266365
0.8278 Intermediate Similarity NPC477206
0.8235 Intermediate Similarity NPC470849
0.8235 Intermediate Similarity NPC470848
0.8227 Intermediate Similarity NPC475138
0.8224 Intermediate Similarity NPC472939
0.8217 Intermediate Similarity NPC269668
0.8212 Intermediate Similarity NPC477483
0.8212 Intermediate Similarity NPC325032
0.82 Intermediate Similarity NPC320734
0.8194 Intermediate Similarity NPC472807
0.8194 Intermediate Similarity NPC471913
0.8188 Intermediate Similarity NPC477207
0.8188 Intermediate Similarity NPC471876
0.8182 Intermediate Similarity NPC471874
0.8163 Intermediate Similarity NPC106055
0.8163 Intermediate Similarity NPC110699
0.8148 Intermediate Similarity NPC309434
0.8148 Intermediate Similarity NPC203124
0.8138 Intermediate Similarity NPC472804
0.8125 Intermediate Similarity NPC476282
0.8121 Intermediate Similarity NPC204644
0.8116 Intermediate Similarity NPC321402
0.8116 Intermediate Similarity NPC478058
0.8108 Intermediate Similarity NPC470035
0.8105 Intermediate Similarity NPC327962
0.8088 Intermediate Similarity NPC263386
0.8088 Intermediate Similarity NPC109371
0.8088 Intermediate Similarity NPC141791
0.8088 Intermediate Similarity NPC470215
0.8088 Intermediate Similarity NPC470214
0.8082 Intermediate Similarity NPC470733
0.8082 Intermediate Similarity NPC120852
0.8071 Intermediate Similarity NPC137416
0.8065 Intermediate Similarity NPC115203
0.8037 Intermediate Similarity NPC472803
0.8015 Intermediate Similarity NPC86198
0.8014 Intermediate Similarity NPC103082
0.8 Intermediate Similarity NPC281277
0.7988 Intermediate Similarity NPC469772
0.7988 Intermediate Similarity NPC469777
0.7988 Intermediate Similarity NPC469774
0.7988 Intermediate Similarity NPC100925
0.7988 Intermediate Similarity NPC469773
0.7988 Intermediate Similarity NPC135334
0.7988 Intermediate Similarity NPC469778
0.7988 Intermediate Similarity NPC32723
0.7988 Intermediate Similarity NPC469776
0.7988 Intermediate Similarity NPC469775
0.7988 Intermediate Similarity NPC295941
0.7987 Intermediate Similarity NPC142654
0.7986 Intermediate Similarity NPC243305
0.7973 Intermediate Similarity NPC475757
0.7973 Intermediate Similarity NPC474640
0.7972 Intermediate Similarity NPC470747
0.7956 Intermediate Similarity NPC70084
0.7941 Intermediate Similarity NPC145023
0.7941 Intermediate Similarity NPC175799
0.7941 Intermediate Similarity NPC610
0.7941 Intermediate Similarity NPC200988
0.7933 Intermediate Similarity NPC67467
0.7931 Intermediate Similarity NPC321502
0.7926 Intermediate Similarity NPC233669
0.7926 Intermediate Similarity NPC474967
0.7914 Intermediate Similarity NPC147654
0.7908 Intermediate Similarity NPC477208
0.7895 Intermediate Similarity NPC163898
0.7895 Intermediate Similarity NPC473909
0.7895 Intermediate Similarity NPC143120
0.7895 Intermediate Similarity NPC274960
0.7887 Intermediate Similarity NPC190849
0.7887 Intermediate Similarity NPC171007
0.7885 Intermediate Similarity NPC478268
0.7883 Intermediate Similarity NPC275519
0.7881 Intermediate Similarity NPC264632
0.7881 Intermediate Similarity NPC476380
0.7881 Intermediate Similarity NPC476378
0.7881 Intermediate Similarity NPC476384
0.7881 Intermediate Similarity NPC477209
0.7881 Intermediate Similarity NPC205864
0.7881 Intermediate Similarity NPC298257
0.7881 Intermediate Similarity NPC96795
0.7881 Intermediate Similarity NPC112
0.7881 Intermediate Similarity NPC247032
0.7881 Intermediate Similarity NPC476375
0.7881 Intermediate Similarity NPC476397
0.7881 Intermediate Similarity NPC476381
0.7881 Intermediate Similarity NPC184935
0.7881 Intermediate Similarity NPC76406
0.7881 Intermediate Similarity NPC269141
0.7881 Intermediate Similarity NPC175214
0.7881 Intermediate Similarity NPC119537
0.7868 Intermediate Similarity NPC137496
0.7868 Intermediate Similarity NPC154511
0.7868 Intermediate Similarity NPC257540
0.7868 Intermediate Similarity NPC247858
0.7868 Intermediate Similarity NPC474358
0.7868 Intermediate Similarity NPC474387
0.7867 Intermediate Similarity NPC476377
0.7867 Intermediate Similarity NPC47471
0.7866 Intermediate Similarity NPC471870
0.7862 Intermediate Similarity NPC125495
0.7862 Intermediate Similarity NPC312341
0.7857 Intermediate Similarity NPC471794
0.7857 Intermediate Similarity NPC95990
0.7857 Intermediate Similarity NPC102934
0.7857 Intermediate Similarity NPC252402
0.7852 Intermediate Similarity NPC81515
0.7852 Intermediate Similarity NPC261453
0.7852 Intermediate Similarity NPC328593
0.7852 Intermediate Similarity NPC68092
0.7852 Intermediate Similarity NPC33749
0.7852 Intermediate Similarity NPC64141
0.7852 Intermediate Similarity NPC197316

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC310621 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8944 High Similarity NPD8166 Discontinued
0.8085 Intermediate Similarity NPD5736 Approved
0.805 Intermediate Similarity NPD8127 Discontinued
0.7931 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7931 Intermediate Similarity NPD3620 Phase 2
0.7862 Intermediate Similarity NPD6663 Approved
0.7852 Intermediate Similarity NPD7266 Discontinued
0.7817 Intermediate Similarity NPD3094 Phase 2
0.7808 Intermediate Similarity NPD4140 Approved
0.7786 Intermediate Similarity NPD3092 Approved
0.7754 Intermediate Similarity NPD3091 Approved
0.7677 Intermediate Similarity NPD6273 Approved
0.7518 Intermediate Similarity NPD3095 Discontinued
0.7517 Intermediate Similarity NPD5735 Approved
0.75 Intermediate Similarity NPD5762 Approved
0.75 Intermediate Similarity NPD5763 Approved
0.7394 Intermediate Similarity NPD3019 Approved
0.7355 Intermediate Similarity NPD7003 Approved
0.7353 Intermediate Similarity NPD3021 Approved
0.7353 Intermediate Similarity NPD3022 Approved
0.7341 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD4060 Phase 1
0.7312 Intermediate Similarity NPD7458 Discontinued
0.731 Intermediate Similarity NPD5327 Phase 3
0.7308 Intermediate Similarity NPD6190 Approved
0.7278 Intermediate Similarity NPD7228 Approved
0.7278 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD2932 Approved
0.7273 Intermediate Similarity NPD4059 Approved
0.7267 Intermediate Similarity NPD8032 Phase 2
0.7261 Intermediate Similarity NPD7236 Approved
0.7254 Intermediate Similarity NPD7741 Discontinued
0.7244 Intermediate Similarity NPD4110 Phase 3
0.7244 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7237 Intermediate Similarity NPD6353 Approved
0.7169 Intermediate Similarity NPD6234 Discontinued
0.7162 Intermediate Similarity NPD4624 Approved
0.716 Intermediate Similarity NPD7028 Phase 2
0.7153 Intermediate Similarity NPD4626 Approved
0.7133 Intermediate Similarity NPD7095 Approved
0.7119 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD7685 Pre-registration
0.7108 Intermediate Similarity NPD7833 Phase 2
0.7108 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD7831 Phase 2
0.7083 Intermediate Similarity NPD5691 Approved
0.7078 Intermediate Similarity NPD7097 Phase 1
0.7075 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD37 Approved
0.707 Intermediate Similarity NPD6674 Discontinued
0.7063 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD6355 Discontinued
0.7059 Intermediate Similarity NPD3657 Discovery
0.7048 Intermediate Similarity NPD4967 Phase 2
0.7048 Intermediate Similarity NPD4965 Approved
0.7048 Intermediate Similarity NPD4966 Approved
0.7037 Intermediate Similarity NPD7239 Suspended
0.7032 Intermediate Similarity NPD7742 Approved
0.7032 Intermediate Similarity NPD7743 Approved
0.7025 Intermediate Similarity NPD4628 Phase 3
0.702 Intermediate Similarity NPD3027 Phase 3
0.7013 Intermediate Similarity NPD6653 Approved
0.6994 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6988 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6986 Remote Similarity NPD3026 Approved
0.6986 Remote Similarity NPD3023 Approved
0.6982 Remote Similarity NPD7199 Phase 2
0.6981 Remote Similarity NPD8131 Suspended
0.6981 Remote Similarity NPD7910 Clinical (unspecified phase)
0.6966 Remote Similarity NPD3024 Approved
0.6966 Remote Similarity NPD3025 Approved
0.6957 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6957 Remote Similarity NPD3645 Discontinued
0.6957 Remote Similarity NPD7446 Clinical (unspecified phase)
0.6946 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6936 Remote Similarity NPD5844 Phase 1
0.6932 Remote Similarity NPD8313 Approved
0.6932 Remote Similarity NPD8312 Approved
0.6923 Remote Similarity NPD4198 Discontinued
0.6918 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6901 Remote Similarity NPD4869 Clinical (unspecified phase)
0.6887 Remote Similarity NPD2861 Phase 2
0.6883 Remote Similarity NPD1613 Approved
0.6883 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6879 Remote Similarity NPD5406 Approved
0.6879 Remote Similarity NPD5404 Approved
0.6879 Remote Similarity NPD5408 Approved
0.6879 Remote Similarity NPD5405 Approved
0.6863 Remote Similarity NPD3764 Approved
0.6857 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6839 Remote Similarity NPD230 Phase 1
0.6829 Remote Similarity NPD1653 Approved
0.6818 Remote Similarity NPD7240 Approved
0.6816 Remote Similarity NPD8150 Discontinued
0.6806 Remote Similarity NPD7157 Approved
0.6802 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6797 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6795 Remote Similarity NPD4097 Suspended
0.679 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6788 Remote Similarity NPD3455 Phase 2
0.6783 Remote Similarity NPD5283 Phase 1
0.6772 Remote Similarity NPD2935 Discontinued
0.6768 Remote Similarity NPD5699 Approved
0.6761 Remote Similarity NPD228 Approved
0.6757 Remote Similarity NPD3496 Discontinued
0.6753 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6753 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6753 Remote Similarity NPD6798 Discontinued
0.6746 Remote Similarity NPD7768 Phase 2
0.6736 Remote Similarity NPD2629 Approved
0.6735 Remote Similarity NPD1357 Approved
0.6733 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6732 Remote Similarity NPD4908 Phase 1
0.6731 Remote Similarity NPD5124 Phase 1
0.6731 Remote Similarity NPD5123 Clinical (unspecified phase)
0.673 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6726 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6726 Remote Similarity NPD8455 Phase 2
0.6724 Remote Similarity NPD7473 Discontinued
0.6711 Remote Similarity NPD6917 Clinical (unspecified phase)
0.671 Remote Similarity NPD7961 Discontinued
0.6691 Remote Similarity NPD3020 Approved
0.6689 Remote Similarity NPD1283 Approved
0.6689 Remote Similarity NPD8651 Approved
0.6688 Remote Similarity NPD7008 Discontinued
0.6667 Remote Similarity NPD27 Approved
0.6667 Remote Similarity NPD826 Approved
0.6667 Remote Similarity NPD7497 Discontinued
0.6667 Remote Similarity NPD6166 Phase 2
0.6667 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6667 Remote Similarity NPD2438 Suspended
0.6667 Remote Similarity NPD825 Approved
0.6667 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6667 Remote Similarity NPD2489 Approved
0.6667 Remote Similarity NPD2898 Approved
0.6647 Remote Similarity NPD7057 Phase 3
0.6647 Remote Similarity NPD7058 Phase 2
0.6647 Remote Similarity NPD6232 Discontinued
0.6646 Remote Similarity NPD3638 Discontinued
0.6646 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6645 Remote Similarity NPD2797 Approved
0.6643 Remote Similarity NPD3134 Approved
0.663 Remote Similarity NPD8434 Phase 2
0.6627 Remote Similarity NPD7819 Suspended
0.6623 Remote Similarity NPD1529 Clinical (unspecified phase)
0.661 Remote Similarity NPD7074 Phase 3
0.6607 Remote Similarity NPD6677 Suspended
0.6606 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6605 Remote Similarity NPD7982 Clinical (unspecified phase)
0.6603 Remote Similarity NPD6233 Phase 2
0.66 Remote Similarity NPD5351 Clinical (unspecified phase)
0.66 Remote Similarity NPD5350 Clinical (unspecified phase)
0.6599 Remote Similarity NPD5536 Phase 2
0.6597 Remote Similarity NPD7094 Approved
0.6597 Remote Similarity NPD7843 Approved
0.6597 Remote Similarity NPD7635 Approved
0.6597 Remote Similarity NPD5535 Approved
0.6597 Remote Similarity NPD6858 Approved
0.6596 Remote Similarity NPD1358 Approved
0.6591 Remote Similarity NPD7799 Discontinued
0.6585 Remote Similarity NPD7040 Clinical (unspecified phase)
0.6585 Remote Similarity NPD7041 Phase 2
0.6584 Remote Similarity NPD7037 Approved
0.6582 Remote Similarity NPD4579 Clinical (unspecified phase)
0.6579 Remote Similarity NPD7680 Approved
0.6568 Remote Similarity NPD1934 Approved
0.6561 Remote Similarity NPD2979 Phase 3
0.6558 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6556 Remote Similarity NPD7311 Approved
0.6556 Remote Similarity NPD7313 Approved
0.6556 Remote Similarity NPD7310 Approved
0.6556 Remote Similarity NPD7312 Approved
0.6554 Remote Similarity NPD7054 Approved
0.6552 Remote Similarity NPD3051 Approved
0.6543 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6543 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6538 Remote Similarity NPD3268 Approved
0.6536 Remote Similarity NPD6362 Approved
0.6529 Remote Similarity NPD5761 Phase 2
0.6529 Remote Similarity NPD5760 Phase 2
0.6522 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6522 Remote Similarity NPD6005 Phase 3
0.6522 Remote Similarity NPD6004 Phase 3
0.6522 Remote Similarity NPD6002 Phase 3
0.6522 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6519 Remote Similarity NPD7309 Approved
0.6519 Remote Similarity NPD1432 Clinical (unspecified phase)
0.6519 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6517 Remote Similarity NPD7472 Approved
0.6514 Remote Similarity NPD2969 Approved
0.6514 Remote Similarity NPD2970 Approved
0.6512 Remote Similarity NPD7075 Discontinued
0.651 Remote Similarity NPD5585 Approved
0.6503 Remote Similarity NPD7906 Approved
0.6503 Remote Similarity NPD6331 Phase 2
0.6503 Remote Similarity NPD3750 Approved
0.65 Remote Similarity NPD2799 Discontinued
0.65 Remote Similarity NPD7033 Discontinued
0.65 Remote Similarity NPD3299 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data